NCT01938755View on ClinicalTrials.gov

Hyperbaric Levobupivacaine for Spinal Anaesthesia

PHASE4CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
This Study Was Focused on Selective Spinal Anesthesia for Lower Extremity Surgery in Order to Achieve Early Mobilization and to Shorten Hospital Stay
Interventions
DRUG

levobupivacaine

levobupivacaine plus 60 mg dextrose

DRUG

levobupivacaine

levobupivacaine plus 80 mg dextrose

DRUG

levobupivacaine

levobupivacaine plus 100 mg dextrose

Trial Locations (1)

52100

Anestesia and Reanimation Dept.; Ordu University Education and Research Hospital, Ordu

All Listed Sponsors
lead

T.C. ORDU ÜNİVERSİTESİ

OTHER

NCT01938755 - Hyperbaric Levobupivacaine for Spinal Anaesthesia | Biotech Hunter | Biotech Hunter